The AI breakthrough in breast cancer detectio...

Up next

A Decade of Waste: Why ITAM Hasn’t Won (Yet)

A decade of better tools. Better services. Better data. And yet the same statistic keeps showing up: 25-30% of enterprise technology spend is wasted. Why can't anyone move the needle? Shane Cronin, Head of ITAM & FinOps Services at SHI International, breaks down why traditional a ... Show more

. 30min 17sec

When AI Can’t Afford to Be Wrong: Inside Bot Auto’s Autonomous Trucking Mission

Everyone’s talking about AI that writes code and answers questions. But what happens when AI has to operate in the physical world, where mistakes don’t just generate weird sentences, they have real consequences? On this episode of Innovation Heroes, host Ed McNamara sits down wit ... Show more

. 27min 22sec

Recommended Episodes

Switzerland, AI and Liquid Biopsies

Faces of Digital Health

AI and predictive modeling to understand an individual’s immune system function and predict treatment response are still in very early stages. We dream about precision medicine and getting every answer we can for ourselves when we get sick. However, if we look at genomics, only a ... Show more

. 36min 51sec

Paige Cofounder Thomas Fuchs’ Diagnosis on Improving Cancer Patient Outcomes With AI - Ep. 228

NVIDIA AI Podcast

Improved cancer diagnostics — and improved patient outcomes — could be among the changes generative AI will bring to the healthcare industry, thanks to Paige, the first company with an FDA-approved tool for cancer diagnosis. In this episode of NVIDIA’s AI Podcast, host Noah Kravi ... Show more

. 33min 11sec

AI for Good: Generative AI’s Impact & Elevating Women in STEM

AI Loves Data Podcast

In this episode of the Data Science Salon Podcast, host Anna Anisin sits down with two powerhouse leaders shaping the future of AI and inclusivity in tech. First, Jennetta George, SVP of AI at AlixPartners & CEO of Artificially Intelligent, shares her expertise on leveraging Gene ... Show more

. 38min 25sec

How AI Will Accelerate Breakthroughs in Biotechnology with Benchling CEO Sajith Wickramasekara

No Priors: Artificial Intelligence | Technology | Startups

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ... Show more

. 48min 13sec